Yukihiro Kishimoto

639 total citations
26 papers, 522 citations indexed

About

Yukihiro Kishimoto is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Yukihiro Kishimoto has authored 26 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yukihiro Kishimoto's work include Liver Disease Diagnosis and Treatment (7 papers), Neonatal Health and Biochemistry (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Yukihiro Kishimoto is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Neonatal Health and Biochemistry (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Yukihiro Kishimoto collaborates with scholars based in Japan, United Kingdom and China. Yukihiro Kishimoto's co-authors include Yoshikazu Murawaki, Takeaki Suou, Masahiko Koda, Manri Kawakami, Keiko Hosho, Goshi Shiota, Chisato Hirayama, Junichi Hasegawa, Hironaka Kawasaki and Yasushi Horie and has published in prestigious journals such as Hepatology, Cancer and Biochemical and Biophysical Research Communications.

In The Last Decade

Yukihiro Kishimoto

24 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yukihiro Kishimoto Japan 11 321 293 103 71 64 26 522
Yoshihiro Kanbara Japan 13 436 1.4× 297 1.0× 144 1.4× 111 1.6× 69 1.1× 30 739
T NAKATANI Japan 9 267 0.8× 225 0.8× 115 1.1× 71 1.0× 28 0.4× 10 540
Ezio David Italy 9 245 0.8× 288 1.0× 122 1.2× 103 1.5× 70 1.1× 9 482
Satoshi Tsunematsu Japan 14 190 0.6× 193 0.7× 126 1.2× 52 0.7× 36 0.6× 35 435
Scott A. Mills United States 8 293 0.9× 268 0.9× 101 1.0× 169 2.4× 40 0.6× 10 524
Hiroyuki Motoyama Japan 10 205 0.6× 194 0.7× 137 1.3× 38 0.5× 79 1.2× 30 450
Chongyang Zhang China 6 290 0.9× 289 1.0× 141 1.4× 92 1.3× 56 0.9× 10 516
Roman Liebe Germany 11 260 0.8× 192 0.7× 135 1.3× 105 1.5× 39 0.6× 36 468
Apinya Leerapun Thailand 10 253 0.8× 152 0.5× 113 1.1× 104 1.5× 45 0.7× 35 483
Yasuhide Motoyoshi Japan 14 279 0.9× 316 1.1× 90 0.9× 50 0.7× 49 0.8× 27 625

Countries citing papers authored by Yukihiro Kishimoto

Since Specialization
Citations

This map shows the geographic impact of Yukihiro Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukihiro Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukihiro Kishimoto more than expected).

Fields of papers citing papers by Yukihiro Kishimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukihiro Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukihiro Kishimoto. The network helps show where Yukihiro Kishimoto may publish in the future.

Co-authorship network of co-authors of Yukihiro Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yukihiro Kishimoto. A scholar is included among the top collaborators of Yukihiro Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukihiro Kishimoto. Yukihiro Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hasegawa, Takashi, et al.. (2022). [A case of foveolar-type gastric adenocarcinoma with a raspberry-like appearance followed up by endoscopy].. PubMed. 119(1). 66–71. 1 indexed citations
2.
Kishimoto, Yukihiro, et al.. (2021). Tool Wear and Wear Mechanism of Carbide Tool in Cutting Al–Si Alloy Diecastings. MATERIALS TRANSACTIONS. 62(4). 526–531. 1 indexed citations
3.
Miura, Norimasa, Yukio Osaki, Kohei Shomori, et al.. (2010). A novel biomarker TERTmRNA is applicable for early detection of hepatoma. BMC Gastroenterology. 10(1). 46–46. 31 indexed citations
4.
Koda, Masahiko, Takakazu Nagahara, Takaaki Sugihara, et al.. (2009). Nucleotide Analogs for Patients with HBV-Related Hepatocellular Carcinoma Increase the Survival Rate through Improved Liver Function. Internal Medicine. 48(1). 11–17. 42 indexed citations
5.
Kanbe, Takamasa, et al.. (2009). [Effectiveness of S-1 therapy for unresectable/advanced pancreas cancer].. PubMed. 36(9). 1475–80. 1 indexed citations
6.
Miura, Norimasa, Shigeo Maruyama, Kenji Oyama, et al.. (2007). Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma. Oncology. 72(Suppl. 1). 45–51. 25 indexed citations
7.
Yamada, Sadako, Kyoko Ishii, Takashi Shimomura, et al.. (2007). Significance of urinary excretion of 8-hydroxy-2'-deoxyguanosine in healthy subjects and liver disease patients.. PubMed. 54(78). 1736–40. 11 indexed citations
8.
Koda, Masahiko, et al.. (2007). Fibroindex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 45(2). 297–306. 205 indexed citations
9.
Kanbe, Takamasa, Yoko Yoshida, Hiroyuki Tsuchiya, et al.. (2006). Naked gene therapy of hepatocyte growth factor for dextran sulfate sodium-induced colitis in mice. Biochemical and Biophysical Research Communications. 345(4). 1517–1525. 11 indexed citations
10.
Ueki, Masaru, Kinya Okamoto, Yoshiko Matsunaga, et al.. (2005). Expression of oxidative stress‐related molecules in circulating leukocytes and urine in patients with chronic viral hepatitis. Liver International. 26(2). 157–165. 15 indexed citations
11.
Miura, Natsuko, Goshi Shiota, Terumichi Nakagawa, et al.. (2003). Sensitive Detection of Human Telomerase Reverse Transcriptase mRNA in the Serum of Patients with Hepatocellular Carcinoma. Oncology. 64(4). 430–434. 56 indexed citations
12.
Kawakami, Manri, et al.. (2001). Adult-type neuroblastoma originated in retroperitoneum beginning with obstructive jaundice. Clinical Imaging. 25(4). 284–287. 6 indexed citations
13.
Hanada, M, Yukihiro Kishimoto, K Nakai, et al.. (2000). [Antithymocyte globulin treatment in 11 patients with aplastic anemia].. PubMed. 41(7). 563–7. 2 indexed citations
14.
Kishimoto, Yukihiro, et al.. (1993). Hepatocellular carcinoma with sarcomatous changes. Case report and imaging diagnosis.. Kanzo. 34(10). 837–843. 3 indexed citations
15.
Kishimoto, Yukihiro, et al.. (1992). Special Issue on Recent High Efficiency and Heavy Grinding. Creep Feed Grinding of Ceramics.. Journal of the Japan Society for Precision Engineering. 58(4). 607–609. 1 indexed citations
16.
Kishimoto, Yukihiro, et al.. (1987). Gonadal function in male patients with alcoholic and non-alcoholic liver disease.. Japanese Journal of Medicine. 26(1). 41–45. 2 indexed citations
17.
Nagai, Toshihiro, et al.. (1986). [Intravenous sedation in dentistry. Use of intravenous sedation with flunitrazepam in dental treatment for handicapped patients].. PubMed. 20(4). 449–56.
18.
Horie, Yutaka, et al.. (1984). Plasma carcinoembryonic antigen and acinar cell carcinoma of the pancreas. Cancer. 53(5). 1137–1142. 10 indexed citations
19.
Hirayama, Chisato, et al.. (1983). Mechanism of the protective action of thiol compounds in ethanol-induced liver injury. Biochemical Pharmacology. 32(2). 321–325. 33 indexed citations
20.
YAMADA, MAYUKO H., et al.. (1982). [A case of chronic idiopathic intestinal pseudoobstruction].. PubMed. 79(6). 1326–30. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026